Medartis Holding AG (MDRSF)
Medartis Holding AG operates in the Medical - Devices industry of the Healthcare sector, headquartered in Basel, BS, CH. The stock last traded at $115.00, up 0.00% on the session, giving a market capitalisation of $1.43B. On trailing twelve-month figures it carries a trailing P/E of 129.70, a net margin of 3.1%. Its beta of 1.17 implies it has historically moved more than the broad market.
Medartis Holding AG is a Switzerland-based medical technology firm, founded in 1997 and headquartered in Basel. The company specializes in the global creation, production, and distribution of advanced implant solutions. These sophisticated medical devices are engineered to support the surgical repair and stabilization of bone fractures, specifically targeting injuries in both upper and lower limbs, as well as intricate cranio-maxillofacial surgeries. Operating under its prominent APTUS and MODUS brands, Medartis provides a comprehensive array of osteosynthesis instruments. These specialized tools and implants are designed for a wide spectrum of anatomical applications, including procedures involving the hand, wrist, elbow, shoulder, foot, and ankle, alongside the mandible, midface, orthognathic, and cranial regions. Medartis serves a diverse international client base, including surgeons, hospitals, medical centers, and various group purchasing organizations.
Medartis Holding AG is most often compared with the following Healthcare names: